359 related articles for article (PubMed ID: 18305228)
41. Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene.
Cherednichenko G; Ward CW; Feng W; Cabrales E; Michaelson L; Samso M; López JR; Allen PD; Pessah IN
Mol Pharmacol; 2008 Apr; 73(4):1203-12. PubMed ID: 18171728
[TBL] [Abstract][Full Text] [Related]
42. Differential Ca(2+) sensitivity of skeletal and cardiac muscle ryanodine receptors in the presence of calmodulin.
Fruen BR; Bardy JM; Byrem TM; Strasburg GM; Louis CF
Am J Physiol Cell Physiol; 2000 Sep; 279(3):C724-33. PubMed ID: 10942723
[TBL] [Abstract][Full Text] [Related]
43. Dantrolene prevents arrhythmogenic Ca2+ release in heart failure.
Maxwell JT; Domeier TL; Blatter LA
Am J Physiol Heart Circ Physiol; 2012 Feb; 302(4):H953-63. PubMed ID: 22180651
[TBL] [Abstract][Full Text] [Related]
44. Sarcoplasmic reticulum lumenal Ca2+ has access to cytosolic activation and inactivation sites of skeletal muscle Ca2+ release channel.
Tripathy A; Meissner G
Biophys J; 1996 Jun; 70(6):2600-15. PubMed ID: 8744299
[TBL] [Abstract][Full Text] [Related]
45. Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor.
Eltit JM; Bannister RA; Moua O; Altamirano F; Hopkins PM; Pessah IN; Molinski TF; López JR; Beam KG; Allen PD
Proc Natl Acad Sci U S A; 2012 May; 109(20):7923-8. PubMed ID: 22547813
[TBL] [Abstract][Full Text] [Related]
46. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
[TBL] [Abstract][Full Text] [Related]
47. Reduced Mg2+ inhibition of Ca2+ release in muscle fibers of pigs susceptible to malignant hyperthermia.
Owen VJ; Taske NL; Lamb GD
Am J Physiol; 1997 Jan; 272(1 Pt 1):C203-11. PubMed ID: 9038826
[TBL] [Abstract][Full Text] [Related]
48. Dantrolene-induced inhibition of skeletal L-type Ca2+ current requires RyR1 expression.
Bannister RA
Biomed Res Int; 2013; 2013():390493. PubMed ID: 23509717
[TBL] [Abstract][Full Text] [Related]
49. Effects of dantrolene on steps of excitation-contraction coupling in mammalian skeletal muscle fibers.
Szentesi P; Collet C; Sárközi S; Szegedi C; Jona I; Jacquemond V; Kovács L; Csernoch L
J Gen Physiol; 2001 Oct; 118(4):355-75. PubMed ID: 11585849
[TBL] [Abstract][Full Text] [Related]
50. Halothane-induced intracellular calcium release in cholinergic cells.
Gomez RS; Guatimosim C; Barbosa J; Massensini AR; Gomez MV; Prado MA
Brain Res; 2001 Dec; 921(1-2):106-14. PubMed ID: 11720716
[TBL] [Abstract][Full Text] [Related]
51. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1).
Roberts MC; Mickelson JR; Patterson EE; Nelson TE; Armstrong PJ; Brunson DB; Hogan K
Anesthesiology; 2001 Sep; 95(3):716-25. PubMed ID: 11575546
[TBL] [Abstract][Full Text] [Related]
52. Ca2+ release in muscle fibers expressing R4892W and G4896V type 1 ryanodine receptor disease mutants.
Lefebvre R; Legrand C; Groom L; Dirksen RT; Jacquemond V
PLoS One; 2013; 8(1):e54042. PubMed ID: 23308296
[TBL] [Abstract][Full Text] [Related]
53. Expression levels of RyR1 and RyR3 control resting free Ca2+ in skeletal muscle.
Perez CF; López JR; Allen PD
Am J Physiol Cell Physiol; 2005 Mar; 288(3):C640-9. PubMed ID: 15548569
[TBL] [Abstract][Full Text] [Related]
54. Skeletal and cardiac ryanodine receptors exhibit different responses to Ca2+ overload and luminal ca2+.
Kong H; Wang R; Chen W; Zhang L; Chen K; Shimoni Y; Duff HJ; Chen SR
Biophys J; 2007 Apr; 92(8):2757-70. PubMed ID: 17259277
[TBL] [Abstract][Full Text] [Related]
55. Postulated role of interdomain interaction between regions 1 and 2 within type 1 ryanodine receptor in the pathogenesis of porcine malignant hyperthermia.
Murayama T; Oba T; Hara H; Wakebe K; Ikemoto N; Ogawa Y
Biochem J; 2007 Mar; 402(2):349-57. PubMed ID: 17107340
[TBL] [Abstract][Full Text] [Related]
56. Measurement of resting cytosolic Ca2+ concentrations and Ca2+ store size in HEK-293 cells transfected with malignant hyperthermia or central core disease mutant Ca2+ release channels.
Tong J; McCarthy TV; MacLennan DH
J Biol Chem; 1999 Jan; 274(2):693-702. PubMed ID: 9873004
[TBL] [Abstract][Full Text] [Related]
57. Ca2+ stores regulate ryanodine receptor Ca2+ release channels via luminal and cytosolic Ca2+ sites.
Laver DR
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):889-96. PubMed ID: 17645636
[TBL] [Abstract][Full Text] [Related]
58. Distinct effects on Ca2+ handling caused by malignant hyperthermia and central core disease mutations in RyR1.
Dirksen RT; Avila G
Biophys J; 2004 Nov; 87(5):3193-204. PubMed ID: 15347586
[TBL] [Abstract][Full Text] [Related]
59. Dantrolene Requires Mg
Diszházi G; Magyar ZÉ; Mótyán JA; Csernoch L; Jóna I; Nánási PP; Almássy J
Mol Pharmacol; 2019 Sep; 96(3):401-407. PubMed ID: 31337666
[TBL] [Abstract][Full Text] [Related]
60. The effect of calcium channel antagonists and BAY K 8644 on calcium fluxes of malignant hyperpyrexia-susceptible muscle.
Foster PS; Denborough MA
Int J Biochem; 1993 Apr; 25(4):495-504. PubMed ID: 7682190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
